...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Response to Koo's Zenith post on RVX
Reply New Message
Prev Message Back To Forum Threaded View Next Message

My comment had nothing to do with the trial and why once again there is a failure around delivery on management set expectations. My comment was only on the failure to update the clinicaltrials.gov website. I’m pretty sure the trial is no longer anticipated to start this past Mar 15. 

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply